Unique Support of Clinical Development
Medicover Integrated Clinical Services (former Synevo Central Labs) is a specialised business unit within Medicover Diagnostic Services division with the overarching objective to help bring innovative therapies and diagnostics to the market working with pharmaceuticals. diagnostics, biopharma, biotech companies and CROs throughout the world.
Our goal is to serve the needs of international life science partners wishing to tap into the expertise, professionalism, enthusiasm, and work ethic in Germany and Central Eastern Europe, by providing the utmost quality at a reasonable cost, leveraging flexible and innovative thinking, disciplined management, and significant economies of scale with an attractive cost base.
The MICS business unit benefits from the full complement of all the latest equipment and methodologies employed by Medicover’s Healthcare and Diagnostics divisions and is therefore fully equipped and uniquely capable of taking on any challenge along the full spectrum of clinical development needs of the demanding life sciences, medical and pharmaceutical industry.
Medicover Integrated Clinical Service’s services include and are organised along discrete lines of activity, including: Central Lab Services, Precision Medicine, Biospecimen Sourcing Management and Patient Recruitment.
Why Medicover Integrated Clinical Services?
Addressing key driver indications e.g. oncology, immunooncology, infectious and chronic diseases
From biomarker discovery to companion diagnostics and product commercialisation
Global central lab services and lab network to support product commercialisation
Dedicated and skilled team available for biomarker / CDx development programs (>100)
Provision of remnants / prospective biosamples for rapid analytical and clinical testing
Enabling through our internal and external network in our core regions in EU, CEE and US
In February we will participate in the Pharmaceutical Business Conference Group! We are proud to be part of a group of speakers representing the clinical trials space, from academia, national
IQVIA – one of the world’s largest CRO becomes Medicover ICS partner in SMO and Patient recruitment area
On 15th of November 2022, in Torun Nasz Lekarz, Medicover ICS entered into a partnership collaboration to be the Prime Site for IQVIA. As of 2017, IQVIA was reported to
Medicover Partners With FYR Diagnostics To Expand Into North America And Enable Additional Precision Medicine Services Offerings. Medicover and FYR Diagnostics (FYR) are proud to announce a new partnership focused
We are proud to announce that Medicover has completed the acquisition of the clinical trial activity of Nasz Lekarz (Our Doctor), one of the leading clinical research centres located in